investigated the synergistic effect of combining RFA and OK-432 in HCC treatment, discovering that OK-432 stimulates the cGAS-STING pathway in DCs, an effect further amplified by RFA (51). The gene discussed is STING1; the disease is hepatocellular carcinoma.